NewslettersExtracellular Matrix NewsUncategorizedAtovaquone-HSA Nano-Drugs Enhance the Efficacy of PD-1 Blockade Immunotherapy by Alleviating Hypoxic Tumor MicroenvironmentBy Justin.choi - October 4, 20210266The authors exploited atovaquone/albumin nanoparticles to improve bioavailability and tumor targeting of atovaquone, enhancing the efficacy of anti-PD-1 therapy by normalizing tumor hypoxia.[Journal of Nanobiotechnology] 7992332 {7992332:AAAAAAAA} apa 50 1 167461 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full ArticleGraphical Abstract